# Azithromycin for Preterm Pre-labor Rupture of Membranes

> **NCT04202380** · NA · COMPLETED · sponsor: **Assiut University** · enrollment: 300 (actual)

## Conditions studied

- Preterm Pre-labor Rupture of Membranes

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Ampicillin
- **DRUG:** Azithromycin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT04202380
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202380, "Azithromycin for Preterm Pre-labor Rupture of Membranes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04202380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*